论文部分内容阅读
The huge prognostic difference between early and late stage hepatocellular carcinoma(HCC)is a challenging diagnostic problem.Alpha-fetoprotein is the mostly widely used biomarker for HCC used in the clinic,however it’s sensitivity and specificity of is no